Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo

BACKGROUND: Silence of the tumor suppressor miR-34c is implicated in the development of colorectal cancer (CRC). For the past few years, Resveratrol (Res) has been introduced to oncotherapies alone or with traditional chemotherapeutic drugs. However, the study of molecular mechanism involved in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shu, Li, Wenshuai, Sun, Haimei, Wu, Bo, Ji, Fengqing, Sun, Tingyi, Chang, Huanhuan, Shen, Ping, Wang, Yaxi, Zhou, Deshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682213/
https://www.ncbi.nlm.nih.gov/pubmed/26674205
http://dx.doi.org/10.1186/s12885-015-1958-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682213/
https://www.ncbi.nlm.nih.gov/pubmed/26674205
http://dx.doi.org/10.1186/s12885-015-1958-6

Ejemplares similares